Wickerhamomyces Yeast Killer Toxins’ Medical Applications
Open Access
- 15 September 2021
- Vol. 13 (9), 655
- https://doi.org/10.3390/toxins13090655
Abstract
Possible implications and applications of the yeast killer phenomenon in the fight against infectious diseases are reviewed, with particular reference to some wide-spectrum killer toxins (KTs) produced by Wickerhamomyces anomalus and other related species. A perspective on the applications of these KTs in the medical field is provided considering (1) a direct use of killer strains, in particular in the symbiotic control of arthropod-borne diseases; (2) a direct use of KTs as experimental therapeutic agents; (3) the production, through the idiotypic network, of immunological derivatives of KTs and their use as potential anti-infective therapeutics. Studies on immunological derivatives of KTs in the context of vaccine development are also described.Keywords
This publication has 78 references indexed in Scilit:
- Antibody Peptide Based Antifungal ImmunotherapyFrontiers in Microbiology, 2012
- Antifungal Activity of Wickerhamomyces anomalus and Lactobacillus plantarum during Sourdough Fermentation: Identification of Novel Compounds and Long-Term Effect during Storage of Wheat BreadApplied and Environmental Microbiology, 2011
- Different mosquito species host Wickerhamomyces anomalus (Pichia anomala): perspectives on vector-borne diseases symbiotic controlAntonie van Leeuwenhoek, 2010
- Safety and regulation of yeasts used for biocontrol or biopreservation in the food or feed chainAntonie van Leeuwenhoek, 2010
- Phylogeny of the ascomycetous yeasts and the renaming of Pichia anomala to Wickerhamomyces anomalusAntonie van Leeuwenhoek, 2010
- Pichia anomala: cell physiology and biotechnology relative to other yeastsAntonie van Leeuwenhoek, 2010
- Pichia anomalaDBVPG 3003 Secretes a Ubiquitin-Like Protein That Has Antimicrobial ActivityApplied and Environmental Microbiology, 2009
- An Anti-β-Glucan Monoclonal Antibody Inhibits Growth and Capsule Formation of Cryptococcus neoformans In Vitro and Exerts Therapeutic, Anticryptococcal Activity In VivoInfection and Immunity, 2007
- Inhibition of Fungal β-1,3-Glucan Synthase and Cell Growth by HM-1 Killer Toxin Single-Chain Anti-Idiotypic AntibodiesAntimicrobial Agents and Chemotherapy, 2006
- Biology of killer yeastsInternational Microbiology, 2002